HomeInsightsStock Comparison

Piramal Pharma Ltd vs Procter Gamble Health Ltd Stock Comparison

Piramal Pharma Ltd vs Procter Gamble Health Ltd Stock Comparison

Last Updated on: Apr 28, 2025

Key Highlights

  • The Latest Trading Price of Piramal Pharma Ltd is ₹ 215.95 as of 28 Apr 09:42.
  • The P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 991.5 on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Procter & Gamble Health Ltd changed from 0 on March 2021 to 0 on March 2024 . This represents a CAGR of 0.0% over 4 years.
  • The Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 17052 crore on March 2024 . This represents a CAGR of 44.51% over 2 yearsThe Market Cap of Procter & Gamble Health Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 4 years.
  • The revenue of Piramal Pharma Ltd for the Dec '24 is ₹ 2233 crore as compare to the Sep '24 revenue of ₹ 2320 crore. This represent the decline of -3.74% The revenue of Procter & Gamble Health Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Piramal Pharma Ltd for the Dec '24 is ₹ 366.92 crore as compare to the Sep '24 ebitda of ₹ 419.98 crore. This represent the decline of -12.63% The ebitda of Procter & Gamble Health Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 3.68 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Procter & Gamble Health Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% .
  • The dividend payout of Piramal Pharma Ltd changed from 18.07 % to 3.72 % over 3 quarters. This represents a CAGR of -87.84% The dividend payout of Procter & Gamble Health Ltd changed from 150.27 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. Piramal Pharma Solution provides integrated drug discovery, development, and manufacturing services for both drug substances, i.e. active pharmaceutical ingredients (APIs) and drug products, i.e. formulations across the life cycle of a molecule, from discovery and clinical development to commercial launch.

About Procter & Gamble Health Ltd

  • Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
  • The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products.
  • They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs. The company operates in two business divisions, namely Pharmaceuticals and Chemicals.
  • The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products.

Piramal Pharma Ltd News Hub

News

Piramal Pharma's Telangana unit starts production of general anesthesia drug Sevoflurane

This was achieved by creating capacity for Sevoflurane manufacture at the Digwal facility ...

Read more

02 Apr 2025 11:25

News

Piramal Pharma Ltd Spurts 3.8%

Piramal Pharma Ltd rose 3.8% today to trade at Rs 229.65. The BSE Healthcare index is up 0...

Read more

21 Mar 2025 09:30

News

Piramal Pharma declines after US FDA issues Form 483 with 6 observations to Turbhe unit

In a regulatory filing made after market hours yesterday, the pharmaceutical company state...

Read more

19 Feb 2025 09:37

News

Piramal Pharma Q3 PAT drops 64% YoY to Rs 4 crore

Profit before tax stood at Rs 66.80 crore in the December 2024 quarter, registering a grow...

Read more

29 Jan 2025 11:53

News

Piramal Pharma launches Chlorpromazine Hydrochloride in US

Chlorpromazine Hydrochloride Injection is a medicine used to treat various disorders such ...

Read more

23 Jan 2025 09:38

News

Piramal Pharma to discuss results

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January ...

Read more

14 Jan 2025 14:25

Procter & Gamble Health Ltd News Hub

News

Procter & Gamble Health declare Quarterly Result

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 29...

Read more

27 Mar 2025 10:23

News

P&G Health gains as Q3 PAT jumps 26% YoY to Rs 91 cr; declares interim dividend of Rs 80/share

The company's revenue from operations remained flat to Rs 309.77 crore in Q3 FY25, compare...

Read more

12 Feb 2025 15:45

News

Board of Procter & Gamble Health recommends interim dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

12 Feb 2025 16:37

News

Procter & Gamble Health announces board meeting date

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 12...

Read more

28 Dec 2024 09:36

News

P&G Health hits 52 week high as Q2 PAT jumps 26% YoY to Rs 82 cr

Profit before tax in Q2 FY25 stood at Rs 111.4 crore, up 26.51% as against Rs 88.05 crore ...

Read more

05 Nov 2024 09:59

News

Procter & Gamble Health to hold board meeting

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 4 ...

Read more

28 Sep 2024 10:06

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Procter & Gamble Health Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Piramal Pharma Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Piramal Pharma Ltd or Procter & Gamble Health Ltd?

Market cap of Piramal Pharma Ltd is 28,636 Cr while Market cap of Procter & Gamble Health Ltd is 8,422 Cr

What are the key factors driving the stock performance of Piramal Pharma Ltd and Procter & Gamble Health Ltd?

The stock performance of Piramal Pharma Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Piramal Pharma Ltd and Procter & Gamble Health Ltd?

As of April 28, 2025, the Piramal Pharma Ltd stock price is INR ₹216.0. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5074.25.

How do dividend payouts of Piramal Pharma Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Piramal Pharma Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions